12-113369144-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_173542.4(PLBD2):c.319G>A(p.Gly107Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00000275 in 1,452,802 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000028 ( 0 hom. )
Consequence
PLBD2
NM_173542.4 missense
NM_173542.4 missense
Scores
1
18
Clinical Significance
Conservation
PhyloP100: 3.80
Genes affected
PLBD2 (HGNC:27283): (phospholipase B domain containing 2) Predicted to enable phospholipase activity. Predicted to be involved in phospholipid catabolic process. Located in extracellular exosome. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.07909712).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLBD2 | NM_173542.4 | c.319G>A | p.Gly107Ser | missense_variant | 2/12 | ENST00000280800.5 | NP_775813.2 | |
PLBD2 | NM_001159727.2 | c.319G>A | p.Gly107Ser | missense_variant | 2/11 | NP_001153199.1 | ||
PLBD2 | XM_017018977.2 | c.-9-3505G>A | intron_variant | XP_016874466.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PLBD2 | ENST00000280800.5 | c.319G>A | p.Gly107Ser | missense_variant | 2/12 | 1 | NM_173542.4 | ENSP00000280800.3 | ||
PLBD2 | ENST00000545182.6 | c.319G>A | p.Gly107Ser | missense_variant | 2/11 | 2 | ENSP00000443463.2 | |||
PLBD2 | ENST00000548997.1 | n.138-3505G>A | intron_variant | 3 | ENSP00000450343.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome AF: 0.00000275 AC: 4AN: 1452802Hom.: 0 Cov.: 31 AF XY: 0.00000277 AC XY: 2AN XY: 721662
GnomAD4 exome
AF:
AC:
4
AN:
1452802
Hom.:
Cov.:
31
AF XY:
AC XY:
2
AN XY:
721662
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Alfa
AF:
Hom.:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2022 | The c.319G>A (p.G107S) alteration is located in exon 2 (coding exon 2) of the PLBD2 gene. This alteration results from a G to A substitution at nucleotide position 319, causing the glycine (G) at amino acid position 107 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L
PrimateAI
Benign
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
0.0060
.;B
Vest4
MutPred
Loss of glycosylation at S106 (P = 0.0379);Loss of glycosylation at S106 (P = 0.0379);
MVP
MPC
0.36
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at